
Navigating the Shift Toward Real-Time Clinical Trials
The FDA’s new initiative for Real-Time Clinical Trials (RTCT) aims to replace traditional periodic data collection with a continuous monitoring framework. As pilot programs launch, industry experts are gathering to evaluate how constant data access will reshape trial oversight, patient safety, and regulatory compliance standards across the pharmaceutical landscape.





















